Subscription banner for an ophthalmic newsletter
Alcon Completes Acquisition of BELKIN Vision

Alcon has finalized its acquisition of BELKIN Vision, marking a significant expansion of its glaucom...

read more
Alcon Completes Acquisition of BELKIN Vision
July 02, 2024
Alcon Plans to Cut 2% of Its Global Workforce to Reduce Costs

Swiss eye care group Alcon is reportedly laying off 2% of its global workforce, including employees ...

read more
Alcon Plans to Cut 2% of Its Global Workforce to Reduce Costs
December 06, 2022
Dr. Allen C. Ho Appointed Chairman of Alcon Research Institute’s Executive Committee

Alcon announced that Allen C. Ho, MD, will join the Alcon Research Institute’s (ARI) Executive Commi...

read more
Dr. Allen C. Ho Appointed Chairman of Alcon Research Institute’s Executive Committee
July 30, 2024
CDSCO Probes Alcon's IOL for Drastically Diminishing Patient's Sight

The Central Drugs Standard Control Organisation (CDSCO) has established a committee to investigate c...

read more
CDSCO Probes Alcon's IOL for Drastically Diminishing Patient's Sight
June 21, 2023
Alcon to Acquire Belkin Vision for Up to $325 Million

Alcon has enhanced its offerings in glaucoma surgery by announcing its acquisition of Belkin Vision,...

read more
Alcon to Acquire Belkin Vision for Up to $325 Million
May 08, 2024
Alcon Launches PRECISION7: First One-Week Contact Lens with ACTIV-FLO Technology

Alcon has announced the U.S. launch of PRECISION7, a groundbreaking contact lens designed for a conv...

read more
Alcon Launches PRECISION7: First One-Week Contact Lens with ACTIV-FLO Technology
November 12, 2024
Alcon Boosts Femtosecond Laser Portfolio with Acquisition of Lensar

Alcon has announced a definitive merger agreement to acquire Lensar, Inc., marking a significant exp...

read more
Alcon Boosts Femtosecond Laser Portfolio with Acquisition of Lensar
March 25, 2025
Alcon Acquires Majority Stake in Aurion Biotech to Advance Cell Therapy for Corneal Disease

Alcon has officially acquired a majority interest in Aurion Biotech, a clinical-stage biotech compan...

read more
Alcon Acquires Majority Stake in Aurion Biotech to Advance Cell Therapy for Corneal Disease
March 28, 2025
FDA Clears Alcon's Unity Vitreoretinal-Cataract System and Unity Standalone Cataract System

Alcon has received FDA 510(k) clearance for its Unity Vitreoretinal Cataract System (VCS) and Unity ...

read more
FDA Clears Alcon's Unity Vitreoretinal-Cataract System and Unity Standalone Cataract System
June 25, 2024
Alcon Launches Experience Academy (AEA) App

Alcon has introduced the Alcon Experience Academy (AEA) app to enhance the digital learning experien...

read more
Alcon Launches Experience Academy (AEA) App
February 21, 2023
More